<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Vinall, Maria</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">Frayling, Timothy</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">Human Genetics and Type 2 Diabetes: Behind the Headlines</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2012</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2012-11-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">30-31</style></pages><abstract><style  face="normal" font="default" size="100%">Significant advancements in the knowledge of human genetics and type 2 diabetes (T2DM) have been made in the last 5 years. Researchers have now identified ∼65 regions of the genome that influence diabetes [Morris AP et al. Nat Genet 2012]. Genetic studies have also become larger. These advances are virtually all tied to improvements in technology that now allow researchers to quickly sequence the genomes of thousands of individual patients and to analyze tens of millions of genetic variants. This article discussed the new biology being derived from genetic research and how it can impact research being conducted in nongenetic areas.</style></abstract><number><style face="normal" font="default" size="100%">16</style></number><volume><style face="normal" font="default" size="100%">12</style></volume></record></records></xml>